Heron therapeutics, inc. /de/ (HRTX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

103,285

71,898

60,108

53,038

23,461

31,836

53,934

258,934

46,575

144,583

65,524

30,277

83,513

13,414

45,640

61,943

68,016

75,180

152,989

171,526

55,556

72,675

86,212

105,012

57,475

72,287

22,597

34,849

45,722

53,506

60,048

12,442

13,444

17,974

21,019

21,331

2,109

Short-term investments

253,061

319,074

196,200

223,000

265,777

300,535

310,866

164,030

67,363

27,796

8,492

78,986

81,703

37,724

43,279

12,700

32,391

55,986

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

34,811

39,879

66,955

66,821

74,007

64,652

53,633

45,886

37,713

41,874

28,851

18,616

10,327

1,960

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

110

Inventory

34,849

24,968

24,172

29,270

31,421

39,032

31,412

27,197

19,418

10,108

5,169

4,801

4,641

5,340

1,983

3,312

2,744

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

12,442

23,245

16,742

8,739

11,539

11,193

10,217

6,577

5,494

3,702

4,554

3,673

3,431

3,705

3,072

3,175

5,050

3,585

2,006

1,895

945

1,057

3,030

518

2,262

638

763

360

427

584

355

557

306

266

301

499

282

Total current assets

438,448

479,064

364,147

380,835

406,205

447,248

460,062

502,624

176,563

228,063

112,590

136,353

183,615

62,143

93,974

81,130

108,201

134,751

154,995

173,421

56,501

73,732

89,242

105,530

59,737

72,925

23,360

35,209

46,149

54,090

60,403

12,999

13,750

18,240

21,320

21,830

2,501

Property and equipment, net

21,908

19,618

16,315

17,910

16,267

14,677

10,581

7,505

6,504

5,981

5,343

5,754

5,680

5,076

4,702

4,471

3,645

3,049

2,982

2,905

2,996

2,820

2,910

2,978

2,926

2,882

2,857

2,733

2,700

1,752

1,228

1,102

1,114

1,075

346

263

357

Right-of-use lease assets

18,239

13,754

12,246

12,667

13,068

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

346

346

254

254

254

254

253

427

316

263

263

263

263

263

130

130

0

45

174

130

130

130

130

130

130

130

153

148

130

130

130

130

130

130

130

28

53

Total assets

478,941

512,782

392,962

411,666

435,794

462,179

470,896

510,556

183,383

234,307

118,196

142,370

189,558

67,482

98,806

85,731

111,846

137,845

158,151

176,456

59,627

76,682

92,282

108,638

62,793

75,937

26,370

38,090

48,979

55,972

61,761

14,231

14,994

19,445

21,796

22,121

2,911

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

11,562

2,758

1,627

7,997

10,811

16,863

9,644

4,979

11,458

18,769

5,337

6,315

4,477

6,814

6,090

8,661

6,861

3,300

2,735

2,987

2,383

2,549

1,475

1,769

3,603

1,264

2,250

5,350

3,825

1,912

1,758

605

890

1,010

433

289

159

Accrued clinical and manufacturing liabilities

35,321

34,614

26,073

25,383

23,602

24,470

14,281

17,986

24,934

26,920

15,517

14,416

11,224

13,207

9,839

9,485

3,735

5,231

5,167

6,342

3,518

3,811

4,530

3,705

-

1,773

-

-

-

-

-

-

-

-

-

-

-

Accrued payroll and employee liabilities

8,770

15,248

10,134

8,982

6,640

13,397

8,457

6,886

5,248

8,860

7,850

7,258

6,122

8,414

8,641

4,674

2,969

4,828

3,389

2,284

1,656

2,731

2,601

1,835

-

2,566

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

32,423

36,535

51,828

45,891

44,351

32,715

27,368

19,702

20,643

17,175

15,398

12,233

7,244

6,288

3,624

2,512

3,217

4,154

3,098

3,074

2,320

2,931

1,218

2,177

-

364

-

-

-

-

-

-

-

-

-

-

-

Current lease liabilities

2,755

1,926

1,721

1,722

2,032

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

0

0

0

2,763

5,560

4,788

5,235

1,099

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

237

Promissory note payable to related party

-

-

-

-

-

-

0

25,000

25,000

25,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,617

-

2,360

3,488

3,149

1,750

1,033

1,056

1,155

1,498

1,121

1,980

461

Accrued disposition costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,088

1,216

1,173

1,082

986

935

703

Convertible notes payable to related parties, net of discount

5,934

5,624

5,354

5,081

4,821

4,574

4,338

4,112

3,894

3,684

3,481

3,285

3,096

2,911

2,732

2,558

2,388

2,222

2,061

1,903

1,749

1,598

1,450

1,306

1,164

1,025

888

754

622

492

365

239

143

103

-

-

0

Total current liabilities

96,765

96,705

96,737

95,056

92,257

92,019

64,088

78,665

91,177

103,171

53,143

48,295

37,398

38,733

30,926

27,890

19,170

19,735

16,450

16,590

11,626

13,620

11,274

10,792

7,384

6,992

5,498

9,592

7,596

4,154

4,244

3,116

3,361

3,693

2,540

3,204

1,560

Non-current lease liabilities

16,708

12,242

10,783

11,251

11,723

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Promissory note payable to related party, non-current

-

-

-

-

-

-

-

-

-

-

25,000

25,000

50,000

50,000

50,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

25

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

35

Total liabilities

113,473

108,947

107,520

106,307

103,980

92,019

-

-

-

-

78,143

73,295

87,398

88,733

80,926

-

-

19,735

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,361

-

2,604

3,229

1,595

Commitments and contingencies (see Note 6)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

Stockholders’ equity:
Preferred stock, $0.01 par value: 2,500 shares authorized; no shares issued or outstanding at December 31, 2019 and 2018

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Common stock

906

903

800

798

789

782

780

775

650

646

546

539

537

394

391

390

363

361

359

356

296

292

292

289

239

237

3,110

3,060

3,058

152

3,024

2,004

2,002

2,002

2,002

401

401

Additional paid-in capital

1,580,903

1,568,317

1,392,089

1,378,368

1,354,722

1,330,186

1,317,232

1,303,957

925,745

913,955

760,472

747,641

737,953

564,343

555,514

546,951

538,585

530,617

522,928

518,424

383,512

378,007

375,329

372,976

311,578

307,578

242,589

237,392

234,865

235,253

230,343

178,840

174,791

173,989

173,168

151,195

149,340

Accumulated other comprehensive income

708

85

103

148

36

-87

-42

-25

-42

-10

0

-6

-30

-17

-17

-1

1

-40

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advance proceeds for private placement units, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,072

-

Accumulated deficit

-1,217,049

-1,165,470

-1,107,550

-1,073,955

-1,023,733

-960,721

-911,162

-872,816

-834,147

-783,455

-720,965

-679,099

-636,300

-585,971

-538,008

-489,499

-446,273

-412,828

-381,586

-358,914

-335,807

-315,237

-294,613

-275,419

-256,408

-238,870

-224,827

-211,954

-196,540

-183,587

-175,850

-169,729

-165,160

-160,239

-155,978

-151,776

-148,425

Total stockholders’ equity

365,468

403,835

285,442

305,359

331,814

370,160

406,808

431,891

92,206

131,136

40,053

69,075

102,160

-21,251

17,880

57,841

92,676

118,110

141,701

159,866

48,001

63,062

81,008

97,846

55,409

68,945

20,872

28,498

41,383

51,818

57,517

11,115

11,633

15,752

19,192

18,892

1,316

Total liabilities and stockholders’ equity

478,941

512,782

392,962

411,666

435,794

462,179

470,896

510,556

183,383

234,307

118,196

142,370

189,558

67,482

98,806

85,731

111,846

137,845

158,151

176,456

59,627

76,682

92,282

108,638

62,793

75,937

26,370

38,090

48,979

55,972

61,761

14,231

14,994

19,445

21,796

22,121

2,911